Market Outlook
The global Oligonucleotides market size was valued at USD 1290.3 million in 2022 and is forecast to a readjusted size of USD 2461.4 million by 2029 with a CAGR of 9.7% during review period.
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics. Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
Global Oligonucleotides key players include Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, etc. Global top five manufacturers hold a share over 45%. North America is the largest market, with a share over 35%, followed by Europe and China, both have a share over 35percent. In terms of product, DNA Oligos is the largest segment, with a share over 65%. And in terms of application, the largest application is Research, followed by Pharmaceutical.
This report is a detailed and comprehensive analysis for global Oligonucleotides market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Oligonucleotides market size and forecasts, in consumption value ($ Million), 2018-2029
Global Oligonucleotides market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Oligonucleotides market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Oligonucleotides market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oligonucleotides
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oligonucleotides market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Integrated DNA Technologies
Agilent
Sigma-aldrich
Eurofins Genomics
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
GeneDesign
TriLink BioTechnologies
SGS DNA
LC Sciences
Twist Bioscience
Creative Biogene
General Biosystems
Segmentation By Type
DNA Oligos
RNA Oligos
Segmentation By Application
Pharmaceutical
Research
Diagnostic
Segmentation By Region
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the oligonucleotides market in 2025?
The oligonucleotides market in 2025 benefits from advances in gene therapies, personalized medicine, and increased research funding. The growing use of oligonucleotides in various therapeutic areas, such as cancer, genetic disorders, and infectious diseases, also adds to the market's strength.
What are the weaknesses of the oligonucleotides market in 2025?
High production costs and the complexity of synthesizing oligonucleotides remain significant challenges. Additionally, regulatory hurdles for new therapies and the market's reliance on specialized infrastructure can slow market expansion.
What are the opportunities in the oligonucleotides market in 2025?
With the ongoing development of mRNA-based vaccines and gene-editing technologies, the market has vast opportunities for growth. Expanding applications in genetic testing, diagnostics, and therapeutics offer potential for new product innovations and revenue streams.
What are the threats to the oligonucleotides market in 2025?
Competitive pressure from other biotech advancements, potential intellectual property challenges, and regulatory changes pose threats to the market. Moreover, public concerns about gene therapies and ethical implications of genetic modifications could affect market dynamics.
Market PESTEL Analysis
What are the political factors affecting the oligonucleotides market in 2025?
Political stability and favorable healthcare policies play a significant role in shaping the oligonucleotides market. Governments investing in biotech innovations, providing grants, and implementing supportive regulations for gene therapies contribute positively to market growth.
How do economic factors impact the oligonucleotides market in 2025?
Economic factors such as healthcare budgets, research funding, and the affordability of new therapies are crucial. Economic downturns could slow investment in research and development, while economic growth may fuel innovation and wider adoption of oligonucleotide-based treatments.
What are the social factors influencing the oligonucleotides market in 2025?
Public acceptance of gene-based therapies, along with growing awareness of genetic diseases, positively influences the oligonucleotides market. However, concerns over ethical issues related to genetic modification could hinder market acceptance and growth.
What technological factors impact the oligonucleotides market in 2025?
Technological advancements in gene editing, RNA therapeutics, and synthetic biology have a direct impact. Innovations in oligonucleotide synthesis, delivery systems, and diagnostic applications are expected to propel market growth and open new avenues for treatment development.
How do environmental factors affect the oligonucleotides market in 2025?
Environmental regulations governing biotechnology manufacturing processes, including waste disposal and resource use, may influence operational costs. However, there is also potential for growth in sustainable biomanufacturing practices within the market.
What legal factors are relevant to the oligonucleotides market in 2025?
Legal factors such as intellectual property rights, patent protections, and regulatory approvals from agencies like the FDA or EMA are essential in determining the success of new products. Changes in patent laws and clinical trial regulations could either enable or restrict market entry.
Market SIPOC Analysis
What are the suppliers in the oligonucleotides market in 2025?
Suppliers in the oligonucleotides market include raw material providers, such as nucleotide manufacturers, reagents, and equipment suppliers for synthesis and purification. These suppliers play a crucial role in ensuring high-quality production and availability of oligonucleotides.
Who are the inputs in the oligonucleotides market in 2025?
Inputs for the oligonucleotides market encompass nucleotides, chemical reagents, synthesis equipment, and technology platforms for oligonucleotide production. Additionally, skilled labor and research expertise are essential for developing and optimizing oligonucleotide-based therapies.
What processes are involved in the oligonucleotides market in 2025?
Key processes include the synthesis of oligonucleotides, quality control, formulation, and delivery system development. Research and development for new therapeutic applications, as well as regulatory compliance processes, are also critical components of the market.
Who are the customers in the oligonucleotides market in 2025?
Customers include pharmaceutical companies, biotechnology firms, academic and research institutions, and contract research organizations (CROs). Additionally, healthcare providers and patients seeking targeted therapies represent an important customer segment.
What are the outputs of the oligonucleotides market in 2025?
Outputs of the oligonucleotides market consist of a variety of products, including therapeutic oligonucleotides, diagnostic kits, and research tools. These outputs aim to address genetic disorders, infectious diseases, and other health challenges, ultimately contributing to advancements in personalized medicine.
Market Porter's Five Forces
What is the threat of new entrants in the oligonucleotides market in 2025?
The threat of new entrants is moderate due to high barriers to entry, such as significant capital investment, specialized expertise, and complex regulatory requirements. However, technological advancements and growing market demand may encourage new players to enter.
What is the bargaining power of suppliers in the oligonucleotides market in 2025?
The bargaining power of suppliers is relatively high as there are few specialized suppliers of raw materials like nucleotides and synthesis equipment. Suppliers with advanced technology and high-quality materials can exert influence on pricing and availability.
What is the bargaining power of buyers in the oligonucleotides market in 2025?
The bargaining power of buyers is moderate. Large pharmaceutical companies and biotech firms, being key customers, have the leverage to negotiate prices. However, the unique nature of oligonucleotide-based products limits the ability of buyers to easily switch suppliers.
What is the threat of substitute products in the oligonucleotides market in 2025?
The threat of substitutes is moderate. While gene therapies and RNA-based drugs are alternatives, oligonucleotides remain a crucial component in treating genetic disorders, making substitutes less viable. However, emerging technologies in gene editing could present competition in the future.
What is the intensity of competitive rivalry in the oligonucleotides market in 2025?
The intensity of competitive rivalry is high. Established companies and innovative biotech firms are actively researching and developing new oligonucleotide-based therapies, leading to intense competition. As the market grows, rivalry is expected to increase, particularly in therapeutic applications.
Market Upstream Analysis
What are the key raw materials required in the oligonucleotides market in 2025?
The key raw materials include nucleotides, reagents for chemical synthesis, and solvents for purification. These materials are essential for the production and development of oligonucleotide-based therapies and diagnostics.
What are the main suppliers in the upstream segment of the oligonucleotides market in 2025?
Main suppliers in the upstream segment are specialized chemical and biotech companies that provide high-quality nucleotides, chemical reagents, and sophisticated equipment for oligonucleotide synthesis and purification.
What are the critical technologies involved in the upstream processes for the oligonucleotides market in 2025?
Key technologies include automated synthesis platforms, purification technologies like HPLC, and advanced sequencing methods. These technologies are essential for ensuring precision and efficiency in oligonucleotide production.
What are the challenges faced in the upstream processes of the oligonucleotides market in 2025?
Challenges in the upstream processes include the high cost of raw materials, maintaining the quality of synthesized oligonucleotides, and the complexity of the synthesis process. Additionally, supply chain disruptions can affect the timely availability of materials.
How does regulation impact the upstream processes in the oligonucleotides market in 2025?
Regulatory requirements for raw materials and production processes are stringent. Compliance with quality standards, safety protocols, and intellectual property laws adds complexity to the upstream segment, potentially increasing costs and development timelines.
Market Midstream Analysis
What are the key processes involved in the midstream segment of the oligonucleotides market in 2025?
The key processes include the synthesis of oligonucleotides, formulation for therapeutic use, quality control, and packaging. In this segment, the focus is on ensuring the high purity and stability of the oligonucleotides for clinical and commercial applications.
What role do service providers play in the midstream segment of the oligonucleotides market in 2025?
Service providers, such as contract manufacturing organizations (CMOs) and contract research organizations (CROs), are crucial in the midstream segment. They offer specialized services like large-scale synthesis, clinical trial support, and regulatory consulting to accelerate the commercialization of oligonucleotide-based therapies.
What are the challenges in the midstream segment of the oligonucleotides market in 2025?
Challenges include the complexity and cost of large-scale synthesis, maintaining product consistency, and ensuring compliance with regulatory standards. Additionally, efficient and cost-effective delivery methods are still under development, posing a challenge for the broader market adoption of these therapies.
How do regulations impact the midstream segment in the oligonucleotides market in 2025?
Regulations significantly impact the midstream segment, particularly around good manufacturing practices (GMP) for clinical and commercial production. Compliance with regulatory bodies like the FDA and EMA is essential to ensure the safety, efficacy, and approval of oligonucleotide-based therapies.
What are the opportunities in the midstream segment of the oligonucleotides market in 2025?
Opportunities lie in advancements in production technology that improve scalability and reduce costs. Furthermore, partnerships between biotech firms and contract manufacturers can drive innovation in oligonucleotide formulations and delivery methods, expanding the market for these therapies.
Market Downstream Analysis
What are the key distribution channels in the downstream segment of the oligonucleotides market in 2025?
The key distribution channels in the downstream segment include pharmaceutical distributors, specialty biotech companies, and online platforms for research and diagnostic tools. Additionally, direct sales teams and partnerships with healthcare providers facilitate access to oligonucleotide-based therapies.
What is the role of healthcare providers in the downstream segment of the oligonucleotides market in 2025?
Healthcare providers, including hospitals, clinics, and specialized medical centers, are crucial in administering oligonucleotide-based therapies to patients. Their role includes diagnosing patients, offering personalized treatment plans, and ensuring proper monitoring of therapy outcomes.
What are the challenges in the downstream segment of the oligonucleotides market in 2025?
Challenges in the downstream segment include the high cost of oligonucleotide therapies, limited awareness among healthcare professionals, and the need for specialized training in gene-based treatments. Additionally, reimbursement issues and market access can slow the adoption of these therapies.
What are the key customer segments in the downstream segment of the oligonucleotides market in 2025?
Key customer segments include patients with genetic disorders, oncology patients, and individuals seeking personalized medicine. Additionally, research institutions and diagnostic labs represent important customers for oligonucleotide-based products used in genetic testing and therapeutic development.
What opportunities exist in the downstream segment of the oligonucleotides market in 2025?
Opportunities lie in expanding market access through better pricing strategies, partnerships with healthcare providers, and improved reimbursement policies. Increasing demand for personalized medicine and advancements in gene therapy will further drive adoption of oligonucleotide-based products in clinical settings.
Chapter 1, to describe Oligonucleotides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oligonucleotides, with revenue, gross margin and global market share of Oligonucleotides from 2018 to 2023.
Chapter 3, the Oligonucleotides competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Oligonucleotides market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Oligonucleotides.
Chapter 13, to describe Oligonucleotides research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Oligonucleotides
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oligonucleotides by Type
1.3.1 Overview: Global Oligonucleotides Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Oligonucleotides Consumption Value Market Share by Type in 2022
1.3.3 DNA Oligos
1.3.4 RNA Oligos
1.4 Global Oligonucleotides Market by Application
1.4.1 Overview: Global Oligonucleotides Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical
1.4.3 Research
1.4.4 Diagnostic
1.5 Global Oligonucleotides Market Size & Forecast
1.6 Global Oligonucleotides Market Size and Forecast by Region
1.6.1 Global Oligonucleotides Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Oligonucleotides Market Size by Region, (2018-2029)
1.6.3 North America Oligonucleotides Market Size and Prospect (2018-2029)
1.6.4 Europe Oligonucleotides Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Oligonucleotides Market Size and Prospect (2018-2029)
1.6.6 South America Oligonucleotides Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Oligonucleotides Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Integrated DNA Technologies
2.1.1 Integrated DNA Technologies Details
2.1.2 Integrated DNA Technologies Major Business
2.1.3 Integrated DNA Technologies Oligonucleotides Product and Solutions
2.1.4 Integrated DNA Technologies Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Integrated DNA Technologies Recent Developments and Future Plans
2.2 Agilent
2.2.1 Agilent Details
2.2.2 Agilent Major Business
2.2.3 Agilent Oligonucleotides Product and Solutions
2.2.4 Agilent Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Agilent Recent Developments and Future Plans
2.3 Sigma-aldrich
2.3.1 Sigma-aldrich Details
2.3.2 Sigma-aldrich Major Business
2.3.3 Sigma-aldrich Oligonucleotides Product and Solutions
2.3.4 Sigma-aldrich Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sigma-aldrich Recent Developments and Future Plans
2.4 Eurofins Genomics
2.4.1 Eurofins Genomics Details
2.4.2 Eurofins Genomics Major Business
2.4.3 Eurofins Genomics Oligonucleotides Product and Solutions
2.4.4 Eurofins Genomics Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Eurofins Genomics Recent Developments and Future Plans
2.5 L.G.C Biosearch Technologies
2.5.1 L.G.C Biosearch Technologies Details
2.5.2 L.G.C Biosearch Technologies Major Business
2.5.3 L.G.C Biosearch Technologies Oligonucleotides Product and Solutions
2.5.4 L.G.C Biosearch Technologies Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 L.G.C Biosearch Technologies Recent Developments and Future Plans
2.6 Eurogentec S.A
2.6.1 Eurogentec S.A Details
2.6.2 Eurogentec S.A Major Business
2.6.3 Eurogentec S.A Oligonucleotides Product and Solutions
2.6.4 Eurogentec S.A Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Eurogentec S.A Recent Developments and Future Plans
2.7 Nitto Denko Avecia Inc
2.7.1 Nitto Denko Avecia Inc Details
2.7.2 Nitto Denko Avecia Inc Major Business
2.7.3 Nitto Denko Avecia Inc Oligonucleotides Product and Solutions
2.7.4 Nitto Denko Avecia Inc Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Nitto Denko Avecia Inc Recent Developments and Future Plans
2.8 GenScript
2.8.1 GenScript Details
2.8.2 GenScript Major Business
2.8.3 GenScript Oligonucleotides Product and Solutions
2.8.4 GenScript Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 GenScript Recent Developments and Future Plans
2.9 BBI Life Sciences
2.9.1 BBI Life Sciences Details
2.9.2 BBI Life Sciences Major Business
2.9.3 BBI Life Sciences Oligonucleotides Product and Solutions
2.9.4 BBI Life Sciences Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 BBI Life Sciences Recent Developments and Future Plans
2.10 GeneDesign
2.10.1 GeneDesign Details
2.10.2 GeneDesign Major Business
2.10.3 GeneDesign Oligonucleotides Product and Solutions
2.10.4 GeneDesign Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 GeneDesign Recent Developments and Future Plans
2.11 TriLink BioTechnologies
2.11.1 TriLink BioTechnologies Details
2.11.2 TriLink BioTechnologies Major Business
2.11.3 TriLink BioTechnologies Oligonucleotides Product and Solutions
2.11.4 TriLink BioTechnologies Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 TriLink BioTechnologies Recent Developments and Future Plans
2.12 SGS DNA
2.12.1 SGS DNA Details
2.12.2 SGS DNA Major Business
2.12.3 SGS DNA Oligonucleotides Product and Solutions
2.12.4 SGS DNA Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 SGS DNA Recent Developments and Future Plans
2.13 LC Sciences
2.13.1 LC Sciences Details
2.13.2 LC Sciences Major Business
2.13.3 LC Sciences Oligonucleotides Product and Solutions
2.13.4 LC Sciences Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 LC Sciences Recent Developments and Future Plans
2.14 Twist Bioscience
2.14.1 Twist Bioscience Details
2.14.2 Twist Bioscience Major Business
2.14.3 Twist Bioscience Oligonucleotides Product and Solutions
2.14.4 Twist Bioscience Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Twist Bioscience Recent Developments and Future Plans
2.15 Creative Biogene
2.15.1 Creative Biogene Details
2.15.2 Creative Biogene Major Business
2.15.3 Creative Biogene Oligonucleotides Product and Solutions
2.15.4 Creative Biogene Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Creative Biogene Recent Developments and Future Plans
2.16 General Biosystems
2.16.1 General Biosystems Details
2.16.2 General Biosystems Major Business
2.16.3 General Biosystems Oligonucleotides Product and Solutions
2.16.4 General Biosystems Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 General Biosystems Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Oligonucleotides Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Oligonucleotides by Company Revenue
3.2.2 Top 3 Oligonucleotides Players Market Share in 2022
3.2.3 Top 6 Oligonucleotides Players Market Share in 2022
3.3 Oligonucleotides Market: Overall Company Footprint Analysis
3.3.1 Oligonucleotides Market: Region Footprint
3.3.2 Oligonucleotides Market: Company Product Type Footprint
3.3.3 Oligonucleotides Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Oligonucleotides Consumption Value and Market Share by Type (2018-2023)
4.2 Global Oligonucleotides Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Oligonucleotides Consumption Value Market Share by Application (2018-2023)
5.2 Global Oligonucleotides Market Forecast by Application (2024-2029)
6 North America
6.1 North America Oligonucleotides Consumption Value by Type (2018-2029)
6.2 North America Oligonucleotides Consumption Value by Application (2018-2029)
6.3 North America Oligonucleotides Market Size by Country
6.3.1 North America Oligonucleotides Consumption Value by Country (2018-2029)
6.3.2 United States Oligonucleotides Market Size and Forecast (2018-2029)
6.3.3 Canada Oligonucleotides Market Size and Forecast (2018-2029)
6.3.4 Mexico Oligonucleotides Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Oligonucleotides Consumption Value by Type (2018-2029)
7.2 Europe Oligonucleotides Consumption Value by Application (2018-2029)
7.3 Europe Oligonucleotides Market Size by Country
7.3.1 Europe Oligonucleotides Consumption Value by Country (2018-2029)
7.3.2 Germany Oligonucleotides Market Size and Forecast (2018-2029)
7.3.3 France Oligonucleotides Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Oligonucleotides Market Size and Forecast (2018-2029)
7.3.5 Russia Oligonucleotides Market Size and Forecast (2018-2029)
7.3.6 Italy Oligonucleotides Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Oligonucleotides Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Oligonucleotides Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Oligonucleotides Market Size by Region
8.3.1 Asia-Pacific Oligonucleotides Consumption Value by Region (2018-2029)
8.3.2 China Oligonucleotides Market Size and Forecast (2018-2029)
8.3.3 Japan Oligonucleotides Market Size and Forecast (2018-2029)
8.3.4 South Korea Oligonucleotides Market Size and Forecast (2018-2029)
8.3.5 India Oligonucleotides Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Oligonucleotides Market Size and Forecast (2018-2029)
8.3.7 Australia Oligonucleotides Market Size and Forecast (2018-2029)
9 South America
9.1 South America Oligonucleotides Consumption Value by Type (2018-2029)
9.2 South America Oligonucleotides Consumption Value by Application (2018-2029)
9.3 South America Oligonucleotides Market Size by Country
9.3.1 South America Oligonucleotides Consumption Value by Country (2018-2029)
9.3.2 Brazil Oligonucleotides Market Size and Forecast (2018-2029)
9.3.3 Argentina Oligonucleotides Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Oligonucleotides Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Oligonucleotides Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Oligonucleotides Market Size by Country
10.3.1 Middle East & Africa Oligonucleotides Consumption Value by Country (2018-2029)
10.3.2 Turkey Oligonucleotides Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Oligonucleotides Market Size and Forecast (2018-2029)
10.3.4 UAE Oligonucleotides Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Oligonucleotides Market Drivers
11.2 Oligonucleotides Market Restraints
11.3 Oligonucleotides Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Oligonucleotides Industry Chain
12.2 Oligonucleotides Upstream Analysis
12.3 Oligonucleotides Midstream Analysis
12.4 Oligonucleotides Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Oligonucleotides Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oligonucleotides Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Oligonucleotides Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Oligonucleotides Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Integrated DNA Technologies Company Information, Head Office, and Major Competitors
Table 6. Integrated DNA Technologies Major Business
Table 7. Integrated DNA Technologies Oligonucleotides Product and Solutions
Table 8. Integrated DNA Technologies Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Integrated DNA Technologies Recent Developments and Future Plans
Table 10. Agilent Company Information, Head Office, and Major Competitors
Table 11. Agilent Major Business
Table 12. Agilent Oligonucleotides Product and Solutions
Table 13. Agilent Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Agilent Recent Developments and Future Plans
Table 15. Sigma-aldrich Company Information, Head Office, and Major Competitors
Table 16. Sigma-aldrich Major Business
Table 17. Sigma-aldrich Oligonucleotides Product and Solutions
Table 18. Sigma-aldrich Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Sigma-aldrich Recent Developments and Future Plans
Table 20. Eurofins Genomics Company Information, Head Office, and Major Competitors
Table 21. Eurofins Genomics Major Business
Table 22. Eurofins Genomics Oligonucleotides Product and Solutions
Table 23. Eurofins Genomics Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Eurofins Genomics Recent Developments and Future Plans
Table 25. L.G.C Biosearch Technologies Company Information, Head Office, and Major Competitors
Table 26. L.G.C Biosearch Technologies Major Business
Table 27. L.G.C Biosearch Technologies Oligonucleotides Product and Solutions
Table 28. L.G.C Biosearch Technologies Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. L.G.C Biosearch Technologies Recent Developments and Future Plans
Table 30. Eurogentec S.A Company Information, Head Office, and Major Competitors
Table 31. Eurogentec S.A Major Business
Table 32. Eurogentec S.A Oligonucleotides Product and Solutions
Table 33. Eurogentec S.A Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Eurogentec S.A Recent Developments and Future Plans
Table 35. Nitto Denko Avecia Inc Company Information, Head Office, and Major Competitors
Table 36. Nitto Denko Avecia Inc Major Business
Table 37. Nitto Denko Avecia Inc Oligonucleotides Product and Solutions
Table 38. Nitto Denko Avecia Inc Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Nitto Denko Avecia Inc Recent Developments and Future Plans
Table 40. GenScript Company Information, Head Office, and Major Competitors
Table 41. GenScript Major Business
Table 42. GenScript Oligonucleotides Product and Solutions
Table 43. GenScript Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. GenScript Recent Developments and Future Plans
Table 45. BBI Life Sciences Company Information, Head Office, and Major Competitors
Table 46. BBI Life Sciences Major Business
Table 47. BBI Life Sciences Oligonucleotides Product and Solutions
Table 48. BBI Life Sciences Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. BBI Life Sciences Recent Developments and Future Plans
Table 50. GeneDesign Company Information, Head Office, and Major Competitors
Table 51. GeneDesign Major Business
Table 52. GeneDesign Oligonucleotides Product and Solutions
Table 53. GeneDesign Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. GeneDesign Recent Developments and Future Plans
Table 55. TriLink BioTechnologies Company Information, Head Office, and Major Competitors
Table 56. TriLink BioTechnologies Major Business
Table 57. TriLink BioTechnologies Oligonucleotides Product and Solutions
Table 58. TriLink BioTechnologies Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. TriLink BioTechnologies Recent Developments and Future Plans
Table 60. SGS DNA Company Information, Head Office, and Major Competitors
Table 61. SGS DNA Major Business
Table 62. SGS DNA Oligonucleotides Product and Solutions
Table 63. SGS DNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. SGS DNA Recent Developments and Future Plans
Table 65. LC Sciences Company Information, Head Office, and Major Competitors
Table 66. LC Sciences Major Business
Table 67. LC Sciences Oligonucleotides Product and Solutions
Table 68. LC Sciences Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. LC Sciences Recent Developments and Future Plans
Table 70. Twist Bioscience Company Information, Head Office, and Major Competitors
Table 71. Twist Bioscience Major Business
Table 72. Twist Bioscience Oligonucleotides Product and Solutions
Table 73. Twist Bioscience Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Twist Bioscience Recent Developments and Future Plans
Table 75. Creative Biogene Company Information, Head Office, and Major Competitors
Table 76. Creative Biogene Major Business
Table 77. Creative Biogene Oligonucleotides Product and Solutions
Table 78. Creative Biogene Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Creative Biogene Recent Developments and Future Plans
Table 80. General Biosystems Company Information, Head Office, and Major Competitors
Table 81. General Biosystems Major Business
Table 82. General Biosystems Oligonucleotides Product and Solutions
Table 83. General Biosystems Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. General Biosystems Recent Developments and Future Plans
Table 85. Global Oligonucleotides Revenue (USD Million) by Players (2018-2023)
Table 86. Global Oligonucleotides Revenue Share by Players (2018-2023)
Table 87. Breakdown of Oligonucleotides by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Oligonucleotides, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 89. Head Office of Key Oligonucleotides Players
Table 90. Oligonucleotides Market: Company Product Type Footprint
Table 91. Oligonucleotides Market: Company Product Application Footprint
Table 92. Oligonucleotides New Market Entrants and Barriers to Market Entry
Table 93. Oligonucleotides Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Oligonucleotides Consumption Value (USD Million) by Type (2018-2023)
Table 95. Global Oligonucleotides Consumption Value Share by Type (2018-2023)
Table 96. Global Oligonucleotides Consumption Value Forecast by Type (2024-2029)
Table 97. Global Oligonucleotides Consumption Value by Application (2018-2023)
Table 98. Global Oligonucleotides Consumption Value Forecast by Application (2024-2029)
Table 99. North America Oligonucleotides Consumption Value by Type (2018-2023) & (USD Million)
Table 100. North America Oligonucleotides Consumption Value by Type (2024-2029) & (USD Million)
Table 101. North America Oligonucleotides Consumption Value by Application (2018-2023) & (USD Million)
Table 102. North America Oligonucleotides Consumption Value by Application (2024-2029) & (USD Million)
Table 103. North America Oligonucleotides Consumption Value by Country (2018-2023) & (USD Million)
Table 104. North America Oligonucleotides Consumption Value by Country (2024-2029) & (USD Million)
Table 105. Europe Oligonucleotides Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Europe Oligonucleotides Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Europe Oligonucleotides Consumption Value by Application (2018-2023) & (USD Million)
Table 108. Europe Oligonucleotides Consumption Value by Application (2024-2029) & (USD Million)
Table 109. Europe Oligonucleotides Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Oligonucleotides Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Oligonucleotides Consumption Value by Type (2018-2023) & (USD Million)
Table 112. Asia-Pacific Oligonucleotides Consumption Value by Type (2024-2029) & (USD Million)
Table 113. Asia-Pacific Oligonucleotides Consumption Value by Application (2018-2023) & (USD Million)
Table 114. Asia-Pacific Oligonucleotides Consumption Value by Application (2024-2029) & (USD Million)
Table 115. Asia-Pacific Oligonucleotides Consumption Value by Region (2018-2023) & (USD Million)
Table 116. Asia-Pacific Oligonucleotides Consumption Value by Region (2024-2029) & (USD Million)
Table 117. South America Oligonucleotides Consumption Value by Type (2018-2023) & (USD Million)
Table 118. South America Oligonucleotides Consumption Value by Type (2024-2029) & (USD Million)
Table 119. South America Oligonucleotides Consumption Value by Application (2018-2023) & (USD Million)
Table 120. South America Oligonucleotides Consumption Value by Application (2024-2029) & (USD Million)
Table 121. South America Oligonucleotides Consumption Value by Country (2018-2023) & (USD Million)
Table 122. South America Oligonucleotides Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Middle East & Africa Oligonucleotides Consumption Value by Type (2018-2023) & (USD Million)
Table 124. Middle East & Africa Oligonucleotides Consumption Value by Type (2024-2029) & (USD Million)
Table 125. Middle East & Africa Oligonucleotides Consumption Value by Application (2018-2023) & (USD Million)
Table 126. Middle East & Africa Oligonucleotides Consumption Value by Application (2024-2029) & (USD Million)
Table 127. Middle East & Africa Oligonucleotides Consumption Value by Country (2018-2023) & (USD Million)
Table 128. Middle East & Africa Oligonucleotides Consumption Value by Country (2024-2029) & (USD Million)
Table 129. Oligonucleotides Raw Material
Table 130. Key Suppliers of Oligonucleotides Raw Materials
List of Figures
Figure 1. Oligonucleotides Picture
Figure 2. Global Oligonucleotides Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oligonucleotides Consumption Value Market Share by Type in 2022
Figure 4. DNA Oligos
Figure 5. RNA Oligos
Figure 6. Global Oligonucleotides Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Oligonucleotides Consumption Value Market Share by Application in 2022
Figure 8. Pharmaceutical Picture
Figure 9. Research Picture
Figure 10. Diagnostic Picture
Figure 11. Global Oligonucleotides Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Oligonucleotides Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Oligonucleotides Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Oligonucleotides Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Oligonucleotides Consumption Value Market Share by Region in 2022
Figure 16. North America Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Oligonucleotides Revenue Share by Players in 2022
Figure 22. Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Oligonucleotides Market Share in 2022
Figure 24. Global Top 6 Players Oligonucleotides Market Share in 2022
Figure 25. Global Oligonucleotides Consumption Value Share by Type (2018-2023)
Figure 26. Global Oligonucleotides Market Share Forecast by Type (2024-2029)
Figure 27. Global Oligonucleotides Consumption Value Share by Application (2018-2023)
Figure 28. Global Oligonucleotides Market Share Forecast by Application (2024-2029)
Figure 29. North America Oligonucleotides Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Oligonucleotides Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Oligonucleotides Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Oligonucleotides Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Oligonucleotides Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Oligonucleotides Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 39. France Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Oligonucleotides Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Oligonucleotides Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Oligonucleotides Consumption Value Market Share by Region (2018-2029)
Figure 46. China Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 49. India Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Oligonucleotides Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Oligonucleotides Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Oligonucleotides Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Oligonucleotides Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Oligonucleotides Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Oligonucleotides Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 63. Oligonucleotides Market Drivers
Figure 64. Oligonucleotides Market Restraints
Figure 65. Oligonucleotides Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Oligonucleotides in 2022
Figure 68. Manufacturing Process Analysis of Oligonucleotides
Figure 69. Oligonucleotides Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
